Voy­ager taps new busi­ness chief amid 'sig­nif­i­cant in­ter­est' from part­ners; On­copep­tides faces an­oth­er CEO, CFO re­set

Beth Shafer was taught to leave a place bet­ter than she found it. As Voy­ager Ther­a­peu­tics’ new chief busi­ness of­fi­cer, that’s ex­act­ly what she in­tends to do.

Voy­ager an­nounced Mon­day that it tapped the Take­da vet­er­an for its C-suite. Shafer will lead the busi­ness strat­e­gy as the com­pa­ny says its AAV cap­sid plat­form and neu­rol­o­gy pro­grams “con­tin­ue to at­tract sig­nif­i­cant in­ter­est from third par­ties.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.